HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Trimethylpsoralen

HCID 5585
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
3902-71-4
Standard SMILES
Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1
InChIKey
FMHHVULEAZTJMA-UHFFFAOYSA-N
Molecular formula
C14H12O3
Average molar mass
228.24 g/mol
Monoisotopic mass
228.07864424

Overview

Trioxsalen is 7H-Furo[3,2-g]chromen-7-one in which positions 2, 5, and 9 are substituted by methyl groups. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered orally in conjunction with UV-A for phototherapy treatment of vitiligo. After photoactivation it creates interstrand cross-links in DNA, inhibiting DNA synthesis and cell division, and can lead to cell injury; recovery from the cell injury may be followed by increased melanisation of the epidermis. It has a role as a photosensitizing agent and a dermatologic drug.

Names & identifiers

Preferred name
Trimethylpsoralen
IUPAC
2,5,9-trimethylfuro[3,2-g]chromen-7-one
English name
TRIOXSALEN
Molecular formula
C14H12O3
Molecular weight
228.24

Names & synonyms

trioxsalen3902-71-4TrioxysalenTrimethylpsoralen4,5',8-TrimethylpsoralenTrioxisalenoTrioxysalene2',4,8-TrimethylpsoralenTrioxysalenumNSC710472,5,9-trimethylfuro[3,2-g]chromen-7-oneTmp (psoralen)
Show more names
LACTONENSC-71047TrioxalenTrioxsaleTrixsalenrioxsalenTRISORALENElder 8011
DTXSID3023716NSC 710477H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl-Y6UY8OV51T2,5,9-Trimethyl-7H-furo(3,2-g)(1)benzopyran-7-one7H-Furo(3,2-g)(1)benzopyran-7-one, 2,5,9-trimethyl-2,5,9-Trimethyl-7H-furo[3,2-g][1]benzopyran-7-oneDTXCID403716

Database identifiers

CAS
3902-71-4
PubChem CID
5585
DTXSID
DTXSID3023716
ChEMBL
CHEMBL1475
ChEBI
CHEBI:28329
UNII
Y6UY8OV51T
EC Number
223-459-0

Properties

Computed structural properties

XLogP
3
Topological polar surface area
39.4 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
3
Rotatable bonds
0
Heavy atoms
17
Formal charge
0
Complexity
374

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
SpringerMaterials PropertiesFusion temperature
LogP3.25
Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physical DescriptionSolid
Collision Cross Section · 2 items

147.4 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

146.69 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
229 · 229-231 °C(lit.)
Boiling point
310.05 °C · 310.05°C (rough estimate)
Density
1.2196 · 1.2196 (rough estimate)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]

P203, P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P318, P321, P363, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Other Safety InformationIMAP assessments - 7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl-: Human health tier I assessment
Hazard Classes and CategoriesSkin Corr. 1B (100%)

Toxicology

Carcinogen Classification · 5 items

4,5',8-Trimethylpsoralen

Group 3: Not classifiable as to its carcinogenicity to humans

Volume 40: (1986) Some Naturally Occurring and Synthetic Food Components, Furocoumarins and Ultraviolet Radiation

1987

1987

Safety data

F
8-10
PPE
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
wgk
2
tsca
TSCA listed
rtecs
LV1576000
ridadr
UN 1759 8/PG 1

Chemistry & industry

Pharmacology

ATC Code · 4 items

D - Dermatologicals

D - Dermatologicals

QD - Dermatologicals

QD - Dermatologicals

PharmacodynamicsTrioxsalen ispharmacologically inactive but when exposed to ultraviolet radiation or sunlight it is converted to its active metabolite to produce a beneficial reaction affecting the diseased tissue.
Mechanism of ActionAfter photoactivation it creates interstrand cross-links in DNA, which can cause programmed cell death.
FDA Pharmacological Classification · 5 items

Y6UY8OV51T

TRIOXSALEN

Established Pharmacologic Class [EPC] - Psoralen

Chemical Structure [CS] - Psoralens

Trioxsalen is a Psoralen.

MeSH Pharmacological Classification · 1 item

Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.

Cellular LocationsCytoplasm

Uses & manufacturing

General Manufacturing Information7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl-: INACTIVE

Applications

Usesmelanizing agent, antipsoriatic

UsesTrioxsalen has been used: to induce small deletion mutations in worms in combination with ultraviolet A (UVA) to induce interstrand crosslinks (ICLs) in DNA for the preparation and photoactivation of trimethyl psoralen

Related reactions

2 records
New reaction record
HRID 225031 reaction equation
HRID 225031As product
HRID 1855734 reaction equation
HRID 1855734As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Nikkaji
J3.411H
refractive index
1.5557 · 1.5557 (estimate)
storage temp.
-20 °C · -20°C
solubility
DMSO: soluble
form
powder
color
white
Merck
14 · 14,9735
BRN
221723 · 221723
InChI
1S/C14H12O3/c1-7-4-12(15)17-14-9(3)13-10(6-11(7)14)5-8(2)16-13/h4-6H,1-3H3
InChIKey
FMHHVULEAZTJMA-UHFFFAOYSA-N
SMILES
Cc1cc2cc3C(C)=CC(=O)Oc3c(C)c2o1
CAS DataBase Reference
3902 · 3902-71-4
FDA UNII
6 UY8OV51T · Y6UY8OV51T
ATC code
5 AD01,D05BA01 · D05AD01,D05BA01
IARC
3 · 3 (Vol. 40, Sup 7) 1987
EPA Substance Registry System
7 H-Furo[3,2-g][1]benzopyran-7-one, · 7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl- (3902-71-4)
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Symbol(GHS)
5 · GHS05,GHS07,GHS08
Signal word
Danger
Hazard statements
312 · H312+H332-H314-H341
Precautionary statements
202 · P202-P260-P280-P303+P361+P353-P304+P340+P310-P305+P351+P338
PPE
3 · Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
Hazard Codes
C
Risk Statements
34 · 34-40
Safety Statements
26 · 26-36/37/39-45
RIDADR
1759 · UN 1759 8/PG 1
WGK Germany
2 · 2
RTECS
1576000 · LV1576000
F
8 · 8-10
TSCA
TSCA listed
HazardClass
8 · 8
PackingGroup
III
HS Code
29322985 · 29322985
Storage Class
8 A · 8A - Combustible corrosive hazardous materials
Hazard Classifications
4 DermalAcute · Acute Tox. 4 DermalAcute Tox. 4 InhalationEye Dam. 1Muta. 2Skin Corr. 1B
hs_code
29322985
risk_code
34-40
Signal word
Danger
Symbol(GHS)
GHS05,GHS07,GHS08
hazard_code
C
safety_code
26-36/37/39-45
hazard_class
8
Storage Class
8A - Combustible corrosive hazardous materials
packing_group
III
Hazard statements
H312+H332-H314-H341
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationEye Dam. 1Muta. 2Skin Corr. 1B
Precautionary statements
P202-P260-P280-P303+P361+P353-P304+P340+P310-P305+P351+P338

Upstream & downstream products

Upstream raw materials

Ethyl acetoacetateEthanolAcetonePotassium carbonate2-MethylresorcinolSulfamic acidMethanolSodium hydroxideN,N-DiethylanilineMagnesium sulfate1,2,3-TribromopropanePotassium bisulfateHydrochloric acidSodium2H-1-Benzopyran-2-one, 7-[(2-chloro-2-propenyl)oxy]-4,8-dimethyl-7-Allyloxy-4,8-dimethyl-chromen-2-one6-allyl-7-hydroxy-4,8-dimethyl-2H-chromen-2-one7-Hydroxy-4,8-dimethylcoumarin
Additional notes · 1 item

DefinitionChEBI: 7H-Furo[3,2-g]chromen-7-one in which positions 2, 5, and 9 are substituted by methyl groups. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered orally in conjunction with UV-A for phot therapy treatment of vitiligo. After photoactivation it creates interstrand cross-links in DNA, inhibiting DNA synthesis and cell division, and can lead to cell injury; recovery from the cell injury may be followed by increased melanisation of the epidermi .